SR ONE CAPITAL MANAGEMENT, LP Activity Q4 2021-Q3 2023

Q2 2023
 Value Shares↓ Weighting
NewARCELLX INC$124,792,4413,946,63053.81%
DSGN NewDESIGN THERAPEUTICS INC$41,116,7996,526,47617.73%
NewMINERALYS THERAPEUTICS INC$30,597,9301,794,60013.19%
SBTX NewARS PHARMACEUTICALS INC$26,886,4504,012,90311.59%
NewEFFECTOR THERAPEUTICS INC$5,594,1336,822,1142.41%
NKTX NewNKARTA INC$2,919,9991,333,3331.26%
Q4 2022
 Value Shares↓ Weighting
ExitEFFECTOR THERAPEUTICS INC$0-6,822,114-1.78%
NKTX ExitNKARTA INC.$0-1,333,333-8.02%
DSGN ExitDESIGN THERAPEUTICS INC$0-5,626,476-43.01%
ExitARCELLX INC.$0-5,500,007-47.19%
Q2 2022
 Value Shares↓ Weighting
NewARCELLX INC.$99,440,0005,500,00748.67%
DSGN NewDESIGN THERAPEUTICS INC$78,771,0005,626,47638.55%
NKTX NewNKARTA INC.$16,427,0001,333,3338.04%
NewEFFECTOR THERAPEUTICS INC$9,687,0006,822,1144.74%

Export SR ONE CAPITAL MANAGEMENT, LP's holdings